Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hai Cheng

Showing results (411-420 of 470) with videos related to

Pageof 47
Sort By:
Naunyn-Schmiedeberg'S Archives of Pharmacology|September 9, 2025
Editorial Expression of Concern: HP-β-CD-PLGA nanoparticles improve the penetration and bioavailability of puerarin and enhance the therapeutic effects on brain ischemia-reperfusion injury in ratsHai-Quan Tao, Qingfeng Meng, Ming-Hui Li, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|November 11, 2022
Factors associated with infection events after chimeric antigen receptor T-cell therapy for relapsed or refractory multiple myelomaDian Zhou, Ying Wang, Hai Cheng, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|November 30, 2012
HP-β-CD-PLGA nanoparticles improve the penetration and bioavailability of puerarin and enhance the therapeutic effects on brain ischemia-reperfusion injury in ratsHai-quan Tao, Qingfeng Meng, Ming-hui Li, et al.
Nature Communications|January 22, 2024
A telomere-targeting drug depletes cancer initiating cells and promotes anti-tumor immunity in small cell lung cancerBuse Eglenen-Polat, Ryan R Kowash, Hai-Cheng Huang, et al.
Clinical Rheumatology|February 9, 2017
Association of serum uric acid and risk of hypertension in adults: a prospective study of Kailuan Corporation cohortLiu-Fu Cui, Hui-Jing Shi, Shou-Ling Wu, et al.
Frontiers in Immunology|November 4, 2022
Prolonged hematological toxicity in patients receiving BCMA/CD19 CAR-T-cell therapy for relapsed or refractory multiple myelomaHujun Li, Lina Zhao, Zengtian Sun, et al.
Nature|March 20, 2020
Coupling of Indo-Pacific climate variability over the last millenniumNerilie J Abram, Nicky M Wright, Bethany Ellis, et al.
Journal of Translational Medicine|November 17, 2018
Platycodin D inhibits platelet function and thrombus formation through inducing internalization of platelet glycoprotein receptorsQi Luo, Guangyu Wei, Xiaoqing Wu, et al.
Frontiers in Oncology|July 1, 2021
An Analysis of Cardiac Disorders Associated With Chimeric Antigen Receptor T Cell Therapy in 126 Patients: A Single-Centre Retrospective StudyKunming Qi, Zhiling Yan, Hai Cheng, et al.
Frontiers in Immunology|November 15, 2021
Humanized Anti-CD19 CAR-T Cell Therapy and Sequential Allogeneic Hematopoietic Stem Cell Transplantation Achieved Long-Term Survival in Refractory and Relapsed B Lymphocytic Leukemia: A Retrospective Study of CAR-T Cell TherapyWei Chen, Yuhan Ma, Ziyuan Shen, et al.
Pageof 47

Showing results (411-420 of 470) with videos related to

Sort By:
Pageof 47
Naunyn-Schmiedeberg'S Archives of Pharmacology|September 9, 2025
Editorial Expression of Concern: HP-β-CD-PLGA nanoparticles improve the penetration and bioavailability of puerarin and enhance the therapeutic effects on brain ischemia-reperfusion injury in ratsHai-Quan Tao, Qingfeng Meng, Ming-Hui Li, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|November 11, 2022
Factors associated with infection events after chimeric antigen receptor T-cell therapy for relapsed or refractory multiple myelomaDian Zhou, Ying Wang, Hai Cheng, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|November 30, 2012
HP-β-CD-PLGA nanoparticles improve the penetration and bioavailability of puerarin and enhance the therapeutic effects on brain ischemia-reperfusion injury in ratsHai-quan Tao, Qingfeng Meng, Ming-hui Li, et al.
Nature Communications|January 22, 2024
A telomere-targeting drug depletes cancer initiating cells and promotes anti-tumor immunity in small cell lung cancerBuse Eglenen-Polat, Ryan R Kowash, Hai-Cheng Huang, et al.
Clinical Rheumatology|February 9, 2017
Association of serum uric acid and risk of hypertension in adults: a prospective study of Kailuan Corporation cohortLiu-Fu Cui, Hui-Jing Shi, Shou-Ling Wu, et al.
Frontiers in Immunology|November 4, 2022
Prolonged hematological toxicity in patients receiving BCMA/CD19 CAR-T-cell therapy for relapsed or refractory multiple myelomaHujun Li, Lina Zhao, Zengtian Sun, et al.
Nature|March 20, 2020
Coupling of Indo-Pacific climate variability over the last millenniumNerilie J Abram, Nicky M Wright, Bethany Ellis, et al.
Journal of Translational Medicine|November 17, 2018
Platycodin D inhibits platelet function and thrombus formation through inducing internalization of platelet glycoprotein receptorsQi Luo, Guangyu Wei, Xiaoqing Wu, et al.
Frontiers in Oncology|July 1, 2021
An Analysis of Cardiac Disorders Associated With Chimeric Antigen Receptor T Cell Therapy in 126 Patients: A Single-Centre Retrospective StudyKunming Qi, Zhiling Yan, Hai Cheng, et al.
Frontiers in Immunology|November 15, 2021
Humanized Anti-CD19 CAR-T Cell Therapy and Sequential Allogeneic Hematopoietic Stem Cell Transplantation Achieved Long-Term Survival in Refractory and Relapsed B Lymphocytic Leukemia: A Retrospective Study of CAR-T Cell TherapyWei Chen, Yuhan Ma, Ziyuan Shen, et al.
Pageof 47